TNF and parasitic infectious disease: We tested both Type I (RH) and Type II (ME49), and despite their differences in virulence, both Type I and Type II strains of T. gondii showed reduced parasitemia in wild-type BMDMs treated with TNF-α and the pan-caspase inhibitor Z-VAD-FMK.